Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DHCR7 divergent transcript (DHCR7-DT) is a long non-coding RNA (lncRNA) gene located on human chromosome 11, also referred to by multiple aliases including AP and RP11-660L16.2[1][3][5]. It does not encode a receptor, enzyme, transporter, or any canonical drug target protein, and has no established biological function, disease association, or clinical biomarker role currently described in reference genomic databases[1][3][5]. There is no evidence in the reviewed sources supporting its use or development as a therapeutic target or its involvement in drug mechanisms of action.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DHCR7 divergent transcript (DHCR7-DT).